NSF has announced its acquisition of Cambium Analytica, an innovative analytical testing and development company serving the natural food, beverage and dietary supplement industries.
With the addition of Cambium Analytica, NSF is now positioned to better meet the accelerating demands of clients, providing them with access to integrated, best-in-class solutions at scale.
This enables companies to grow demand for natural food, beverage and supplement products while ensuring safety and quality, particularly in those seeking to innovate in these industries.
“By integrating Cambium Analytica’s cutting-edge operations with NSF’s eight decades of leadership in safety and testing, we continue to strengthen our position as the partner of choice for clients across the food and nutrition industries,” said Pedro Sancha, President and CEO, NSF.
“Together, we anticipate accelerated growth, expanded capabilities and the addition of exceptional talent to our team.”
Operating as a part of NSF’s largest division, Food and Nutrition, the addition of Cambium Analytica’s capabilities to NSF’s fastest-growing business allows the organisation to stay ahead of market trends and client needs.
“Cambium Analytica stands out for its unwavering commitment to agility, innovation and a deep understanding of the specific needs of natural product brands,” said Sarah Krol, VP, Food and Nutrition, NSF.
"These qualities distinguish them in the marketplace and make them an ideal fit for our food and nutrition service portfolio."
Acquisitions have been named a commercial focus for NSF and the organisation is committed to growth, doubling down on global expansion, streamlining operations and building a groundbreaking innovation machine to stay ahead of market demands.
To fully capture the opportunities created by this acquisition, NSF will work closely with the Cambium Analytica leaders to create a seamless experience for clients globally.
“This partnership represents the perfect alignment of Cambium Analytica's innovative, customer-centric approach with NSF's long-established excellence in public health and safety,” said Alex Adams, CEO of Cambium Analytica.
“Together, we're positioned to lead the next wave of growth in the rapidly evolving consumer products industry – uniting disruptive agility and deep scientific expertise to create an innovative testing and inspection ecosystem.”
The acquisition bridges critical gaps in the natural products market.
Cambium’s timely in-process QA and batch release testing, contract research and product development services will integrate seamlessly with NSF’s audit-focused certification programmes, offering clients complete support from concept through market compliance.
At this time, Cambium Analytica will be renamed Cambium Analytica, an NSF company and its 69 employees will continue to operate out of its Traverse City, Michigan, headquarters.